Zhejiang GCAP Biomed Led.
- Other products or services
- CMO, CRO
About Us
Zhejiang GCAP Biomed Co., Ltd is a leading healthcare service provider based in Hangzhou, China. Specializing in drug safety evaluation and regulatory submissions, GCAP collaborates with 30+ former and current experts from NMPA China’s Center for Drug Evaluation, ensuring regulatory precision.
Core Services
- GLP & GCP Research: 20,000 m² GLP-certified lab, 100,000 m² expansion planned.
- IND & NDA Submissions: Expert-driven regulatory support for drug approvals.
- Post-Registration Compliance: Ethical marketing, physician education, and pharmacovigilance.
Competitive Edge
- >90% regulatory compliance across NMPA, FDA, and EMA.
- 500+ clinical site partnerships, reducing R&D costs by 40%.
- Global expansion expertise, enabling multi-market registration.
GCAP delivers efficient, compliant, and internationally recognized drug evaluation solutions.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}